|
MRNA
|
Moderna, Inc.
|
9.72%
|
US
|
NASDAQ
|
|
BGNE
|
BeiGene, Ltd.
|
8.35%
|
US
|
NASDAQ
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
7.39%
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
7.17%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
7.06%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
6.31%
|
US
|
NASDAQ
|
|
GRTS
|
Gritstone Oncology, Inc.
|
5.03%
|
US
|
NASDAQ
|
|
RNA
|
Avidity Biosciences, Inc.
|
5.00%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
4.89%
|
US
|
NASDAQ
|
|
CVAC
|
CureVac N.V.
|
4.44%
|
US
|
NASDAQ
|
|
ARCT
|
Arcturus Therapeutics Ltd.
|
4.41%
|
US
|
NASDAQ
|
|
DYN
|
Dyne Therapeutics, Inc.
|
3.78%
|
US
|
NASDAQ
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
3.65%
|
US
|
NASDAQ
|
|
SRNE
|
Sorrento Therapeutics, Inc.
|
3.23%
|
US
|
NASDAQ
|
|
PEPG
|
PepGen Inc.
|
2.95%
|
US
|
NASDAQ
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
2.83%
|
US
|
NASDAQ
|
|
STOK
|
Stoke Therapeutics, Inc.
|
2.82%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
2.81%
|
US
|
NASDAQ
|
|
MRVI
|
Maravai LifeSciences Holdings, Inc.
|
2.76%
|
US
|
NASDAQ
|